Biotechnology Reagents & Kits Market (By Technology: PCR, Cell Culture, LAMP, Chromatography, Sequencing, Flow Cytometry, Electrophoresis, and Others; By Kits Type: Amplifications Kits, Isolation Kits, Purification Kits, Detection Kits, and Others; By Micro-Organisms: Virus, Bacteria, Fungi, and Parasites; By Tested Parameters: RNA, DNA, Enzymes, Proteins, and Others; By End Use) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2021 - 2030

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Biotechnology Reagents & Kits Market 

5.1. COVID-19 Landscape: Biotechnology Reagents & Kits Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Biotechnology Reagents & Kits Market, By Kits Type

8.1. Biotechnology Reagents & Kits Market, by Kits Type, 2021-2030

8.1.1. Amplifications Kits

8.1.1.1. Market Revenue and Forecast (2019-2030)

8.1.2. Isolation Kits

8.1.2.1. Market Revenue and Forecast (2019-2030)

8.1.3. Purification Kits

8.1.3.1. Market Revenue and Forecast (2019-2030)

8.1.4. Detection Kits

8.1.4.1. Market Revenue and Forecast (2019-2030)

8.1.5. Others

8.1.5.1. Market Revenue and Forecast (2019-2030)

Chapter 9. Global Biotechnology Reagents & Kits Market, By Micro-Organisms Type

9.1. Biotechnology Reagents & Kits Market, by Micro-Organisms Type, 2021-2030

9.1.1. Virus

9.1.1.1. Market Revenue and Forecast (2019-2030)

9.1.2. Bacteria

9.1.2.1. Market Revenue and Forecast (2019-2030)

9.1.3. Fungi

9.1.3.1. Market Revenue and Forecast (2019-2030)

9.1.4. Parasites

9.1.4.1. Market Revenue and Forecast (2019-2030)

Chapter 10. Global Biotechnology Reagents & Kits Market, By Technology Type 

10.1. Biotechnology Reagents & Kits Market, by Technology Type, 2021-2030

10.1.1. PCR

10.1.1.1. Market Revenue and Forecast (2019-2030)

10.1.2. Cell Culture

10.1.2.1. Market Revenue and Forecast (2019-2030)

10.1.3. LAMP

10.1.3.1. Market Revenue and Forecast (2019-2030)

10.1.4. Chromatography

10.1.4.1. Market Revenue and Forecast (2019-2030)

10.1.5. Sequencing

10.1.5.1. Market Revenue and Forecast (2019-2030)

10.1.6. Flow Cytometry

10.1.6.1. Market Revenue and Forecast (2019-2030)

10.1.7. Electrophoresis

10.1.7.1. Market Revenue and Forecast (2019-2030)

10.1.8. Others

10.1.8.1. Market Revenue and Forecast (2019-2030)

Chapter 11. Global Biotechnology Reagents & Kits Market, By Tested Parameters Type

11.1. Biotechnology Reagents & Kits Market, by Tested Parameters Type, 2021-2030

11.1.1. RNA

11.1.1.1. Market Revenue and Forecast (2019-2030)

11.1.2. DNA

11.1.2.1. Market Revenue and Forecast (2019-2030)

11.1.3. Enzymes

11.1.3.1. Market Revenue and Forecast (2019-2030)

11.1.4. Proteins

11.1.4.1. Market Revenue and Forecast (2019-2030)

11.1.5. Others

11.1.5.1. Market Revenue and Forecast (2019-2030)

Chapter 12. Global Biotechnology Reagents & Kits Market, By End User Type

12.1. Biotechnology Reagents & Kits Market, by End User, 2021-2030

12.1.1. Healthcare

12.1.1.1. Market Revenue and Forecast (2019-2030)

12.1.2. Food & Agriculture

12.1.2.1. Market Revenue and Forecast (2019-2030)

12.1.3. Industrial Processing

12.1.3.1. Market Revenue and Forecast (2019-2030)

12.1.4. Natural Resource & Environment

12.1.4.1. Market Revenue and Forecast (2019-2030)

12.1.5. Others

12.1.5.1. Market Revenue and Forecast (2019-2030)

Chapter 13. Global Biotechnology Reagents & Kits  Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Kits (2019-2030)

13.1.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)

13.1.3. Market Revenue and Forecast, by Technology (2019-2030)

13.1.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)

13.1.5. Market Revenue and Forecast, by End User (2019-2030)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Kits (2019-2030)

13.1.6.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)

13.1.6.3. Market Revenue and Forecast, by Technology (2019-2030)

13.1.6.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)

13.1.7. Market Revenue and Forecast, by End User (2019-2030) 

13.1.8. Rest of North America

13.1.8.1. Market Revenue and Forecast, by Kits (2019-2030)

13.1.8.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)

13.1.8.3. Market Revenue and Forecast, by Technology (2019-2030)

13.1.8.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)

13.1.8.5. Market Revenue and Forecast, by End User (2019-2030)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Kits (2019-2030)

13.2.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)

13.2.3. Market Revenue and Forecast, by Technology (2019-2030)

13.2.4. Market Revenue and Forecast, by Tested Parameters (2019-2030) 

13.2.5. Market Revenue and Forecast, by End User (2019-2030) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Kits (2019-2030)

13.2.6.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)

13.2.6.3. Market Revenue and Forecast, by Technology (2019-2030)

13.2.7. Market Revenue and Forecast, by Tested Parameters (2019-2030) 

13.2.8. Market Revenue and Forecast, by End User (2019-2030) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Kits (2019-2030)

13.2.9.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)

13.2.9.3. Market Revenue and Forecast, by Technology (2019-2030)

13.2.10. Market Revenue and Forecast, by Tested Parameters (2019-2030)

13.2.11. Market Revenue and Forecast, by End User (2019-2030)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Kits (2019-2030)

13.2.12.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)

13.2.12.3. Market Revenue and Forecast, by Technology (2019-2030)

13.2.12.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)

13.2.13. Market Revenue and Forecast, by End User (2019-2030)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Kits (2019-2030)

13.2.14.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)

13.2.14.3. Market Revenue and Forecast, by Technology (2019-2030)

13.2.14.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)

13.2.15. Market Revenue and Forecast, by End User (2019-2030)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Kits (2019-2030)

13.3.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)

13.3.3. Market Revenue and Forecast, by Technology (2019-2030)

13.3.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)

13.3.5. Market Revenue and Forecast, by End User (2019-2030)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Kits (2019-2030)

13.3.6.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)

13.3.6.3. Market Revenue and Forecast, by Technology (2019-2030)

13.3.6.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)

13.3.7. Market Revenue and Forecast, by End User (2019-2030)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Kits (2019-2030)

13.3.8.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)

13.3.8.3. Market Revenue and Forecast, by Technology (2019-2030)

13.3.8.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)

13.3.9. Market Revenue and Forecast, by End User (2019-2030)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Kits (2019-2030)

13.3.10.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)

13.3.10.3. Market Revenue and Forecast, by Technology (2019-2030)

13.3.10.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)

13.3.10.5. Market Revenue and Forecast, by End User (2019-2030)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Kits (2019-2030)

13.3.11.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)

13.3.11.3. Market Revenue and Forecast, by Technology (2019-2030)

13.3.11.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)

13.3.11.5. Market Revenue and Forecast, by End User (2019-2030)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Kits (2019-2030)

13.4.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)

13.4.3. Market Revenue and Forecast, by Technology (2019-2030)

13.4.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)

13.4.5. Market Revenue and Forecast, by End User (2019-2030)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Kits (2019-2030)

13.4.6.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)

13.4.6.3. Market Revenue and Forecast, by Technology (2019-2030)

13.4.6.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)

13.4.7. Market Revenue and Forecast, by End User (2019-2030)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Kits (2019-2030)

13.4.8.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)

13.4.8.3. Market Revenue and Forecast, by Technology (2019-2030)

13.4.8.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)

13.4.9. Market Revenue and Forecast, by End User (2019-2030)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Kits (2019-2030)

13.4.10.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)

13.4.10.3. Market Revenue and Forecast, by Technology (2019-2030)

13.4.10.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)

13.4.10.5. Market Revenue and Forecast, by End User (2019-2030)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Kits (2019-2030)

13.4.11.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)

13.4.11.3. Market Revenue and Forecast, by Technology (2019-2030)

13.4.11.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)

13.4.11.5. Market Revenue and Forecast, by End User (2019-2030)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Kits (2019-2030)

13.5.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)

13.5.3. Market Revenue and Forecast, by Technology (2019-2030)

13.5.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)

13.5.5. Market Revenue and Forecast, by End User (2019-2030)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Kits (2019-2030)

13.5.6.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)

13.5.6.3. Market Revenue and Forecast, by Technology (2019-2030)

13.5.6.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)

13.5.7. Market Revenue and Forecast, by End User (2019-2030)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Kits (2019-2030)

13.5.8.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)

13.5.8.3. Market Revenue and Forecast, by Technology (2019-2030)

13.5.8.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)

13.5.8.5. Market Revenue and Forecast, by End User (2019-2030)

Chapter 14. Company Profiles

14.1. Abbott Laboratories

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Agilent Technologies

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Danaher Corp.

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Becton Dickinson & Company

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Bio-Rad Laboratories

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. GE Healthcare

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Siemens Healthcare

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Merck KGaA

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Thermo Fisher Scientific Inc.

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Waters Corporation

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

PROCEED TO BUY

   USD 4500
   USD 7000
   USD 9000

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence client

Get a Sample